Unified Protocol for Emotional Disorders in University Students: Protocol for a Randomized Trial of Online and Blended Formats
Abstract
Objectives: Psychological problems frequently emerge between ages 15 and 24, often coinciding with the university period. In Spain, anxiety and depressive disorders are prevalent among university students, yet only a small fraction receive treatment. This randomized controlled trial aims to compare the effectiveness, acceptability, and implementation of UP in online group format versus a blended format among university students with EDs at the University of Córdoba.
Method: Participants (n = 70) will be randomly assigned to either condition. The study includes pre-intervention, post-intervention, and follow-up assessments at one and 3 months. Primary outcomes are improvements in anxiety, depression, emotional regulation, and distress tolerance. Secondary outcomes include program adherence and acceptability.
Results: Data will be analyzed using SPSS, employing tests for normality, descriptive statistics, t-tests, repeated measures ANOVA, and linear mixed models to evaluate differences and changes over time. Effect sizes will be calculated, and implementation outcomes will be assessed through descriptive analysis. Improvements are expected to be obtained in the assessed outcome variables in all evaluation periods in both intervention conditions and that are maintained over time. No statistically significant differences are expected to be obtained between the two conditions. Participants are expected to report high acceptability and satisfaction scores regarding the…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 70 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.